Abstract
Objectives
Venous invasion is common in advanced renal cell carcinoma (RCC) due to the unique biology of this cancer. The presence of a tumor thrombus often makes clinical management challenging. In this review, we detail specific preoperative, perioperative, and surgical strategies involving the care of the complex kidney cancer patient with venous tumor involvement.
Methods
We performed a comprehensive review of selected peer-reviewed publications regarding RCC tumor thrombus biology, medical and surgical management techniques, and immediate and long-term outcomes.
Results
The perioperative management may require special imaging techniques, preoperative testing, very recent imaging, and consultation with other surgical services. There are various approaches to these patients as the clinical presentation, stage of disease, primary tumor size, level of thrombus, degree of venous occlusion, presence of bland thrombus, and primary tumor laterality influence management. Select patients with metastatic disease can do well with cytoreductive nephrectomy and thrombectomy. Those with localized disease have a high risk of recurrence; however, some patients can exhibit durable survival with surgery alone. The evolving surgical and medical treatments are discussed.
Conclusions
Even when these surgeries are performed in high volume centers, significant perioperative complications are common and greater complications are seen with higher thrombus extent. If surgery is attempted, it is important for urologic oncologists to follow strict attention to specific surgical principles. These general principles include complete vascular control, avoidance of thrombus embolization, close hemodynamic monitoring, and institutional resources for caval resection/replacement and venous bypass if necessary.
Similar content being viewed by others
References
Siegel R, Naishadham D, Jemal A (2013) Cancer statistics. CA Cancer J Clin 63(1):11–30. doi:10.3322/caac.21166
Zisman A, Wieder JA, Pantuck AJ, Chao DH, Dorey F, Said JW, Gitlitz BJ, deKernion JB, Figlin RA, Belldegrun AS (2003) Renal cell carcinoma with tumor thrombus extension: biology, role of nephrectomy and response to immunotherapy. J Urol 169(3):909–916
Skinner DG, Pritchett TR, Lieskovsky G, Boyd SD, Stiles QR (1989) Vena caval involvement by renal cell carcinoma. Surgical resection provides meaningful long-term survival. Annu Surg 210(3):387–392 discussion 392–384
Wotkowicz C, Wszolek MF, Libertino JA (2008) Resection of renal tumors invading the vena cava. Urol Clin North Am 35(4):657–671. doi:10.1016/j.ucl.2008.07.013 viii
Hallscheidt PJ, Fink C, Haferkamp A, Bock M, Luburic A, Zuna I, Noeldge G, Kauffmann G (2005) Preoperative staging of renal cell carcinoma with inferior vena cava thrombus using multidetector CT and MRI: prospective study with histopathological correlation. J Comput Assist Tomogr 29(1):64–68
Guzzo TJ, Pierorazio PM, Schaeffer EM, Fishman EK, Allaf ME (2009) The accuracy of multidetector computerized tomography for evaluating tumor thrombus in patients with renal cell carcinoma. J Urol 181(2):486–490. doi:10.1016/j.juro.2008.10.040 discussion 491
Lawrentschuk N, Gani J, Riordan R, Esler S, Bolton DM (2005) Multidetector computed tomography vs magnetic resonance imaging for defining the upper limit of tumour thrombus in renal cell carcinoma: a study and review. BJU Int 96(3):291–295. doi:10.1111/j.1464-410X.2005.05617.x
Pouliot F, Shuch B, Larochelle JC, Pantuck A, Belldegrun AS (2010) Contemporary management of renal tumors with venous tumor thrombus. J Urol 184(3):833–841. doi:10.1016/j.juro.2010.04.071 quiz 1235
Neves RJ, Zincke H (1987) Surgical treatment of renal cancer with vena cava extension. Br J Urol 59(5):390–395
Abel EJ, Wood CG, Eickstaedt N, Fang JE, Kenney P, Bagrodia A, Youssef RF, Sagalowsky AI, Margulis V (2013) Preoperative pulmonary embolism does not predict poor postoperative outcomes in patients with renal cell carcinoma and venous thrombus. J Urol 190(2):452–457. doi:10.1016/j.juro.2013.02.033
Shuch B, Larochelle JC, Onyia T, Vallera C, Margulis D, Pantuck AJ, Smith RB, Belldegrun AS (2009) Intraoperative thrombus embolization during nephrectomy and tumor thrombectomy: critical analysis of the University of California-Los Angeles experience. J Urol 181(2):492–499. doi:10.1016/j.juro.2008.10.036
Woodruff DY, Van Veldhuizen P, Muehlebach G, Johnson P, Williamson T, Holzbeierlein JM (2013) The perioperative management of an inferior vena caval tumor thrombus in patients with renal cell carcinoma. Urol Oncol 31(5):517–521. doi:10.1016/j.urolonc.2011.03.006
Novick AC, Kaye MC, Cosgrove DM, Angermeier K, Pontes JE, Montie JE, Streem SB, Klein E, Stewart R, Goormastic M (1990) Experience with cardiopulmonary bypass and deep hypothermic circulatory arrest in the management of retroperitoneal tumors with large vena caval thrombi. Annu Surg 212(4):472–476 discussion 476–477
Subramanian VS, Stephenson AJ, Goldfarb DA, Fergany AF, Novick AC, Krishnamurthi V (2009) Utility of preoperative renal artery embolization for management of renal tumors with inferior vena caval thrombi. Urology 74(1):154–159
Shuch B, Riggs SB, LaRochelle JC, Kabbinavar FF, Avakian R, Pantuck AJ, Patard JJ, Belldegrun AS (2008) Neoadjuvant targeted therapy and advanced kidney cancer: observations and implications for a new treatment paradigm. BJU Int 102(6):692–696
Karakiewicz PI, Suardi N, Jeldres C, Audet P, Ghosn P, Patard JJ, Perrotte P (2008) Neoadjuvant sutent induction therapy may effectively down-stage renal cell carcinoma atrial thrombi. Eur Urol 53(4):845–848
Peters I, Winkler M, Juttner B, Teebken OE, Herrmann TR, von Klot C, Kramer M, Reichelt A, Abbas M, Kuczyk MA, Merseburger AS (2014) Neoadjuvant targeted therapy in a primary metastasized renal cell cancer patient leads to down-staging of inferior vena cava thrombus (IVC) enabling a cardiopulmonary bypass-free tumor nephrectomy: a case report. World J Urol 32(1):245–248. doi:10.1007/s00345-012-0955-5
Cost NG, Delacroix SE Jr, Sleeper JP, Smith PJ, Youssef RF, Chapin BF, Karam JA, Culp S, Abel EJ, Brugarolas J, Raj GV, Sagalowsky AI, Wood CG, Margulis V (2011) The impact of targeted molecular therapies on the level of renal cell carcinoma vena caval tumor thrombus. Eur Urol 59(6):912–918. doi:10.1016/j.eururo.2011.02.032
Bigot P, Fardoun T, Bernhard JC, Xylinas E, Berger J, Roupret M, Beauval JB, Lagabrielle S, Lebdai S, Ammi M, Baumert H, Escudier B, Grenier N, Hetet JF, Long JA, Paparel P, Rioux-Leclercq N, Soulie M, Azzouzi AR, Bensalah K, Patard JJ (2014) Neoadjuvant targeted molecular therapies in patients undergoing nephrectomy and inferior vena cava thrombectomy: is it useful? World J Urol 32(1):109–114. doi:10.1007/s00345-013-1088-1
Chen H, Ng V, Kane CJ, Russell IA (2004) The role of transesophageal echocardiography in rapid diagnosis and treatment of migratory tumor embolus. Anesth Analg 99(2):357–359. doi:10.1213/01.ANE.0000133001.42742.49 table of contents
Abaza R (2011) Robotic surgery and minimally invasive management of renal tumors with vena caval extension. Curr Opin Urol 21(2):104–109. doi:10.1097/MOU.0b013e32834350ff
Ciancio G, Gonzalez J, Shirodkar SP, Angulo JC, Soloway MS (2011) Liver transplantation techniques for the surgical management of renal cell carcinoma with tumor thrombus in the inferior vena cava: step-by-step description. Eur Urol 59(3):401–406. doi:10.1016/j.eururo.2010.07.028
Ciancio G, Vaidya A, Savoie M, Soloway M (2002) Management of renal cell carcinoma with level III thrombus in the inferior vena cava. J Urol 168(4 Pt 1):1374–1377
Torzilli G, Procopio F, Donadon M, Del Fabbro D, Cimino M, Montorsi M (2012) Safety of intermittent Pringle maneuver cumulative time exceeding 120 min in liver resection: a further step in favor of the “radical but conservative” policy. Annu Surg 255(2):270–280. doi:10.1097/SLA.0b013e318232b375
Zini L, Destrieux-Garnier L, Leroy X, Villers A, Haulon S, Lemaitre L, Koussa M (2008) Renal vein ostium wall invasion of renal cell carcinoma with an inferior vena cava tumor thrombus: prediction by renal and vena caval vein diameters and prognostic significance. J Urol 179(2):450–454. doi:10.1016/j.juro.2007.09.042 discussion 454
Hyams ES, Pierorazio PM, Shah A, Lum YW, Black J, Allaf ME (2011) Graft reconstruction of inferior vena cava for renal cell carcinoma stage pT3b or greater. Urology 78(4):838–843. doi:10.1016/j.urology.2011.06.016
Blute ML, Boorjian SA, Leibovich BC, Lohse CM, Frank I, Karnes RJ (2007) Results of inferior vena caval interruption by greenfield filter, ligation or resection during radical nephrectomy and tumor thrombectomy. J Urol 178(2):440–445 discussion 444
Shuch B, Crispen PL, Leibovich BC, Larochelle JC, Pouliot F, Pantuck AJ, Liu W, Crepel M, Schuckman A, Rigaud J, Bouchot O, Patard JJ, Skinner D, Belldegrun AS, Blute ML (2011) Cardiopulmonary bypass and renal cell carcinoma with level IV tumour thrombus: can deep hypothermic circulatory arrest limit perioperative mortality? BJU Int 107(5):724–728. doi:10.1111/j.1464-410X.2010.09488.x
Shaw BW Jr, Martin DJ, Marquez JM, Kang YG, Bugbee AC Jr, Iwatsuki S, Griffith BP, Hardesty RL, Bahnson HT, Starzl TE (1984) Venous bypass in clinical liver transplantation. Annu Surg 200(4):524–534
Blute ML, Leibovich BC, Lohse CM, Cheville JC, Zincke H (2004) The mayo clinic experience with surgical management, complications and outcome for patients with renal cell carcinoma and venous tumour thrombus. BJU Int 94(1):33–41
Abel EJ, Thompson RH, Margulis V, Heckman JE, Merril MM, Darwish OM, Krabbe LM, Boorjian SA, Leibovich BC, Wood CG (2013) Perioperative outcomes following surgical resection of renal cell carcinoma with inferior vena cava thrombus extending above the hepatic veins: a contemporary multicenter experience. Eur Urol. doi:10.1016/j.eururo.2013.10.029
Klatte T, Pantuck AJ, Riggs SB, Kleid MD, Shuch B, Zomorodian N, Kabbinavar FF, Belldegrun AS (2007) Prognostic factors for renal cell carcinoma with tumor thrombus extension. J Urol 178(4 Pt 1):1189–1195 discussion 1195
Margulis V, Tamboli P, Matin SF, Meisner M, Swanson DA, Wood CG (2007) Redefining pT3 renal cell carcinoma in the modern era: a proposal for a revision of the current TNM primary tumor classification system. Cancer 109(12):2439–2444
Goetzl MA, Goluboff ET, Murphy AM, Katz AE, Mansukhani M, Sawczuk IS, Olsson CA, Benson MC, McKiernan JM (2004) A contemporary evaluation of cytoreductive nephrectomy with tumor thrombus: morbidity and long-term survival. Urol Oncol 22(3):182–187. doi:10.1016/j.urolonc.2004.02.001
Shuch B, La Rochelle JC, Wu J, Klatte T, Riggs SB, Kabbinavar F, Belldegrun AS, Pantuck AJ (2008) Performance status and cytoreductive nephrectomy: redefining management in patients with poor performance. Cancer 113(6):1324–1331
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Agochukwu, N., Shuch, B. Clinical management of renal cell carcinoma with venous tumor thrombus. World J Urol 32, 581–589 (2014). https://doi.org/10.1007/s00345-014-1276-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00345-014-1276-7